ATE384781T1 - Verfahren zur herstellung von entwickelten und unentwickelten pankreasendokrinezellen, zellpräparat und verwendung davon zur behandlung von diabetes - Google Patents
Verfahren zur herstellung von entwickelten und unentwickelten pankreasendokrinezellen, zellpräparat und verwendung davon zur behandlung von diabetesInfo
- Publication number
- ATE384781T1 ATE384781T1 AT00201326T AT00201326T ATE384781T1 AT E384781 T1 ATE384781 T1 AT E384781T1 AT 00201326 T AT00201326 T AT 00201326T AT 00201326 T AT00201326 T AT 00201326T AT E384781 T1 ATE384781 T1 AT E384781T1
- Authority
- AT
- Austria
- Prior art keywords
- endocrine cells
- undeveloped
- pancreatic endocrine
- cell preparation
- treating diabetes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00201326A EP1146117B1 (de) | 2000-04-12 | 2000-04-12 | Verfahren zur Herstellung von entwickelten und unentwickelten Pankreasendokrinezellen, Zellpräparat und Verwendung davon zur Behandlung von Diabetes |
CA2363971A CA2363971C (en) | 2000-04-12 | 2001-11-26 | A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE384781T1 true ATE384781T1 (de) | 2008-02-15 |
Family
ID=32070512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00201326T ATE384781T1 (de) | 2000-04-12 | 2000-04-12 | Verfahren zur herstellung von entwickelten und unentwickelten pankreasendokrinezellen, zellpräparat und verwendung davon zur behandlung von diabetes |
Country Status (8)
Country | Link |
---|---|
US (1) | US6686197B2 (de) |
EP (1) | EP1146117B1 (de) |
AT (1) | ATE384781T1 (de) |
CA (1) | CA2363971C (de) |
DE (1) | DE60037876T2 (de) |
DK (1) | DK1146117T3 (de) |
ES (1) | ES2299417T3 (de) |
PT (1) | PT1146117E (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005533480A (ja) * | 2001-11-09 | 2005-11-10 | アーテセル・サイエンシズ・インコーポレーテツド | 脂肪組織由来間質細胞の膵内分泌分化およびその使用 |
AU2003210959A1 (en) * | 2002-02-12 | 2003-09-04 | Cornell Research Foundation, Inc. | Identification and high-yield isolation of human pancreatic islet progenitor and stem cells |
CA2527626A1 (en) | 2003-06-20 | 2004-12-29 | Vrije Universiteit Brussel | Method of generating islet beta-cells from exocrine pancreatic cells |
US20140017304A1 (en) | 2011-03-29 | 2014-01-16 | Myriam Bosmans | Method for encapsulated therapeutic products and uses thereof |
EP2771693A1 (de) * | 2011-10-28 | 2014-09-03 | Centre National de la Recherche Scientifique (CNRS) | Verfahren zur diagnostischen, prognostischen und therapeutischen überwachung von soliden tumoren |
EP3046567A1 (de) * | 2013-09-19 | 2016-07-27 | Beta-Cell N.V. | Verfahren zur behandlung von diabetes mellitus |
SG11201602232UA (en) | 2013-09-24 | 2016-04-28 | Giner Inc | System for gas treatment of a cell implant |
RU2019114817A (ru) | 2016-11-15 | 2020-11-16 | Джинер Лайф Сайенс, Инк. | Устройство чрезкожной диффузии газов, подходящее для применения с подкожным имплантатом |
CA3062412A1 (en) | 2017-05-04 | 2018-11-08 | Giner Life Sciences, Inc. | Robust, implantable gas delivery device and methods, systems and devices including same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5050612A (en) * | 1989-09-12 | 1991-09-24 | Matsumura Kenneth N | Device for computer-assisted monitoring of the body |
US5858973A (en) * | 1994-02-23 | 1999-01-12 | The General Hospital Corporation | Transcription factor and uses therefor |
US6110743A (en) * | 1995-02-10 | 2000-08-29 | The Regents Of The University Of California | Development and use of human pancreatic cell lines |
-
2000
- 2000-04-12 ES ES00201326T patent/ES2299417T3/es not_active Expired - Lifetime
- 2000-04-12 DE DE60037876T patent/DE60037876T2/de not_active Expired - Lifetime
- 2000-04-12 AT AT00201326T patent/ATE384781T1/de active
- 2000-04-12 EP EP00201326A patent/EP1146117B1/de not_active Expired - Lifetime
- 2000-04-12 DK DK00201326T patent/DK1146117T3/da active
- 2000-04-12 PT PT00201326T patent/PT1146117E/pt unknown
-
2001
- 2001-04-12 US US09/834,096 patent/US6686197B2/en not_active Expired - Lifetime
- 2001-11-26 CA CA2363971A patent/CA2363971C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6686197B2 (en) | 2004-02-03 |
CA2363971A1 (en) | 2003-05-26 |
DE60037876D1 (de) | 2008-03-13 |
DK1146117T3 (da) | 2008-05-26 |
EP1146117A1 (de) | 2001-10-17 |
EP1146117B1 (de) | 2008-01-23 |
PT1146117E (pt) | 2008-05-06 |
DE60037876T2 (de) | 2009-01-29 |
US20020177228A1 (en) | 2002-11-28 |
ES2299417T3 (es) | 2008-06-01 |
CA2363971C (en) | 2011-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69525151T2 (de) | Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat | |
AU3513395A (en) | Biological material pre-fixation treatment | |
DE69823361D1 (de) | Herstellung von kollagen | |
DE69715824T2 (de) | Verfahren zur herstellung eines implantierbaren verbundwerkstoffs, so hergestellte werkstoffe, und kit zur durchführung des verfahrens | |
ATE195555T1 (de) | Verfahren zur herstellung transformierter zellen | |
ATE330002T1 (de) | Verfahren zur herstellung von membranvesikeln | |
WO2002040630A3 (en) | Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering | |
DE69737023D1 (de) | Methode zur behandlung von krebs und pathogenen infektionen unter verwendung von antigen-präsentierenden zellen beladen mit rna | |
ATE405644T1 (de) | Verfahren zur herstellung und reinigung von erythropoietin | |
ATE257396T1 (de) | Verfahren zur herstellung von stabilem alginatmaterial | |
ATE384781T1 (de) | Verfahren zur herstellung von entwickelten und unentwickelten pankreasendokrinezellen, zellpräparat und verwendung davon zur behandlung von diabetes | |
ATE3866T1 (de) | Verfahren zur herstellung einer kollagenloesung, eine solche loesung sowie ihre verwendung. | |
DE602005002461D1 (de) | Einen nanofiltrationsschritt umfassendes verfahren zur aufreinigung von albumin, lösung und zusammensetzung zur therapeutischen anwendung, die dieses enthalten | |
DE58907855D1 (de) | Verfahren zur herstellung von rinder-pericard-materialien und ihre verwendung. | |
DE69513186T2 (de) | Photokatalysator, methode zur dessen herstellung, und erzeugung von wasserstoff unter verwendung des photokatalysators | |
ATE307203T1 (de) | Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma | |
DE69722900D1 (de) | Verfahren zur Herstellung von einer stabilen Troponin-Zubereitung und ihre Verwendung als Kalibrator/Kontrolle in Immunoassays | |
DE69431092T2 (de) | Medizinischer Zement, Verfahren zu seiner Herstellung sowie dessen Verwendung | |
DE19981493D2 (de) | Verfahren zur Herstellung einer biologischen Substanz sowie derartige Substanz und deren Verwendung | |
DE3585416D1 (de) | Verfahren zur herstellung eines biologischen stoffes. | |
DE69531496D1 (de) | Alginatfasern, verfahren zur herstellung und verwendung | |
ATE398664T1 (de) | Verfahren zur herstellung eines multifunktionalen additivs und dessen verwendung | |
ATE452643T1 (de) | Herstellung eines biologischen faktors und schaffung einer immunologisch vorteilhaften umgebung unter verwendung genetisch veränderter sertolizellen | |
Akimoto et al. | Reconstruction of basement membrane in recombinants of epidermis and dermis of chick embryonic skin in vitro: An electron microscopic study | |
ATE192191T1 (de) | Methode zur verbesserten herstellung einer produzierende zellinie durch verwendung eines fusionsprotokolls |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1146117 Country of ref document: EP |